Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2024.1391356
Abstract: Background Teriparatide is approved for osteoporosis. Post-marketing surveillance is critical given its widespread use. Objective To investigate adverse events (AEs) associated with teriparatide using the FAERS database, compare association strengths for key AEs, and explore… read more here.
Keywords: indications adverse; system; adverse events; teriparatide based ... See more keywords